These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27017438)

  • 1. Leukapheresis in the management of drug rash with eosinophilia and systemic symptoms syndrome.
    Martínez de Lagrán I; Marcos P; Batlle M; Alonso E; Plana A; Tomasa T
    Med Intensiva; 2017 Apr; 41(3):191-193. PubMed ID: 27017438
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberculosis control programme guidelines--treatment regimens.
    Durrheim DN; Belt EL
    S Afr Med J; 1996 Oct; 86(10):1293-4. PubMed ID: 8955740
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis.
    Guo N; Marra F; Fitzgerald JM; Elwood RK; Marra CA
    Eur Respir J; 2010 Jul; 36(1):206-8. PubMed ID: 20595167
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute liver failure in a pediatric patient with disseminated tuberculosis.
    Whitney J; Hurwitz M; Mojtahed A; Hwang C; Gallo A
    Dig Dis Sci; 2011 Oct; 56(10):2780-3. PubMed ID: 21695402
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.
    García-Rodríguez JF; Valcarce-Pardeiro N; Álvarez-Díaz H; Mariño-Callejo A
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2121-2126. PubMed ID: 31377953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of tuberculous peritonitis developed during chemotherapy for tuberculous pleurisy as paradoxical response].
    Kim SY; Oh TH; Seo JY; Hong JH; Jeon TJ; Seo DD; Shin WC; Choi WC
    Korean J Gastroenterol; 2011 Jun; 57(6):379-83. PubMed ID: 21694492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [DRESS syndrome secondary to pyrazinamide: An uncommon complication of tuberculosis treatment].
    Kombila UD; Ka W; Mbaye FBR; Diouf NF; Fall L; Ouedraogo P; Koutonin ANE; Dia Kane Y; Oumar Toure Badiane N
    Rev Mal Respir; 2018 Jan; 35(1):69-73. PubMed ID: 29429561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the 3-drug combination, Rifater, versus 4-drug therapy in the ambulatory treatment of tuberculosis in Cape Town.
    Macnab MF; Bohmer PD; Seager JR
    S Afr Med J; 1994 Jun; 84(6):325-8. PubMed ID: 7740377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antituberculosis agents.
    Goldberger MJ
    Med Clin North Am; 1988 May; 72(3):661-8. PubMed ID: 3280912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-month regimen of isoniazid, rifampin and pirazinamid for latent tuberculosis infection.
    Duarte R; Carvalho A; Correia A
    Public Health; 2012 Sep; 126(9):760-2. PubMed ID: 22633080
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple Drug Hypersensitivity Syndrome to Antituberculosis Drugs: A Case Report.
    Carneiro-Leão L; Gomes I; Freitas C; Costa E Silva M; Viseu R; Cernadas J
    J Investig Allergol Clin Immunol; 2020; 30(1):70-71. PubMed ID: 31530510
    [No Abstract]   [Full Text] [Related]  

  • 12. [Concomitant Drug Reaction with Eosinophilia and Systemic Symptom Syndrome from Ethambutol and Autoimmune Hepatitis from Isoniazid].
    Choi JH; Heo NY; Park SH; Park CS; Jo KM; Kim WG; Nam KH
    Korean J Gastroenterol; 2016 May; 67(5):267-271. PubMed ID: 27206439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical worsening in tuberculosis during therapy in an HIV-infected patient.
    Mofredj A; Guérin JM; Leibinger F; Masmoudi R
    Infection; 1996; 24(5):390-1. PubMed ID: 8923052
    [No Abstract]   [Full Text] [Related]  

  • 14. [Optochiasmatic tuberculomas as a paradoxical reaction to treatment for meningeal tuberculosis].
    Soto-Cabrera E; Villamil-Osorio LV; Garcia-Luna RC; Carrera-Pineda R
    Rev Neurol; 2018 Apr; 66(8):286-288. PubMed ID: 29645073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima--Peru.
    Morales S; Ramos W; Vílchez R; Pérez J; Alvarado M
    Neurologia; 2011 May; 26(4):220-6. PubMed ID: 21163196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of isoniazid-induced liver injury diagnosed by use of the DLST, and successful reintroduction of isoniazid for pleural tuberculosis.
    Ikegame S; Wakamatsu K; Fujita M; Nakanishi Y; Kajiki A
    J Infect Chemother; 2011 Aug; 17(4):530-3. PubMed ID: 21188445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antituberculous agents.
    Van Scoy RE; Wilkowske CJ
    Mayo Clin Proc; 1987 Dec; 62(12):1129-36. PubMed ID: 3682957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic insufficiency due to antituberculous therapy.
    Liu BA; Knowles SR; Cohen LB; Werb MR; Shear NH
    Ann Pharmacother; 1997 Jun; 31(6):724-6. PubMed ID: 9184712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of pleural and pulmonary tuberculosis by drug combinations including rifampicin. Early results].
    Cornudella R; Garcia-Besada JA; Castellano A
    Rev Clin Esp; 1972 Jul; 126(1):59-64. PubMed ID: 5080189
    [No Abstract]   [Full Text] [Related]  

  • 20. [Myrin P in the combined treatment of tuberculosis].
    Sokolova GB; Semenova OV; Bogadel'nikova IV; Kunichan AD; Zeliger LR; Elistratova NA
    Antibiot Khimioter; 2002; 47(6):22-7. PubMed ID: 12422644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.